Last update:

Immunology news

Oncology & Cancer

New technique improves T cell-based immunotherapies for solid tumors

Scientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can more effectively kill tumor ...

Immunology

Experimental vaccine targets portions of the flu virus that don't change

Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable.

HIV & AIDS

Study highlights importance of early interventions to combat HIV

A study has compared the development of HIV reservoirs—locations in the body where the virus persists in a latent state—between patients who receive either early or late medical interventions. The findings highlight the ...

Immunology

Protein responsible for genetic inflammatory disease identified

A team of researchers led by Dr. Hirotsugu Oda at the University of Cologne's CECAD Cluster of Excellence for Aging Research has discovered the role a specific protein complex plays in certain forms of immune dysregulation. ...

Immunology

Scientists develop new organoid model to study thymus function

Researchers from the Organoid group have developed a new organoid model that can be used to study the thymus. The organoids are derived from mouse thymus tissue, specifically model thymic epithelial cells (TECs). These cells ...

Immunology

How the immune system learns from harmless particles

Our lungs are bombarded by all manner of different particles every single day. While some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The immune system trains its response whenever ...

Diseases, Conditions, Syndromes

Experts develop immune-enhancing therapies to target tuberculosis

Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. ...

Immunology

How B cells recognize new variants of SARS-CoV-2

B cells are part of the immune system's memory. Their memories of previous infections or vaccinations provide the template for antibodies that have a protective effect the next time they come into contact with a pathogen.

Oncology & Cancer

Improving cancer immunotherapy by prolonging T-cell survival

In the past decade, immunotherapy has emerged as the fourth pillar of cancer treatment, joining surgery, radiotherapy and chemotherapy. It is an approved treatment for 15 cancers, including melanoma and some types of lymphomas ...

Oncology & Cancer

Genetically engineering a treatment for incurable brain tumors

Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional ...